Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2005
08/03/2005CN1649616A Methods and compositions for the treatment of ischemia
08/03/2005CN1649614A Active agent delivery systems and methods for protecting and administering active agents
08/03/2005CN1649612A Induction method for cell differentiation
08/03/2005CN1649611A Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
08/03/2005CN1649610A Isolation, purification and structural identification of a bioactive component of a water soluble extract of a botanical species for enhancing immune, anti-inflammatory, anti-tumor and DNA repair proc
08/03/2005CN1649609A Soybean saponin-containing material and process for producing the same
08/03/2005CN1649607A A process for the extraction of anthocyanins from black rice and composition thereof
08/03/2005CN1649604A Separate type medical material
08/03/2005CN1649603A Aqueous compositions containing metronidazole
08/03/2005CN1649602A Re-epithelializing pharmaceutical compositions comprising xanthan gum
08/03/2005CN1649601A Difructose anhydride-containing composition and use thereof
08/03/2005CN1649600A Glycuronamides, glycosides and orthoester glycosides of fluoxetine, analogs and uses thereof
08/03/2005CN1649599A Substituted aminoalkanephosphonic acids for the treatment ofneuropathic pain, affective and attention disorders, schizophrenia, tinnitus, myopia and other ocular disorders
08/03/2005CN1649598A High dose ibandronate formulation
08/03/2005CN1649597A Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
08/03/2005CN1649596A Treatment of hypertension in women receiving hormone replacement therapy
08/03/2005CN1649595A Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
08/03/2005CN1649593A Use of 2-alkoxyphenyl-substituted imidazotriazinones
08/03/2005CN1649592A Pharmaceutical composition
08/03/2005CN1649591A Tricyclic compounds useful as HIV reverse transcriptase inhibitors
08/03/2005CN1649590A Therapeutic agent comprising lafutidine
08/03/2005CN1649589A The treatment of pain with ifendropil
08/03/2005CN1649588A New pharmaceutical compositions based on anticholinergics and PED-IV inhibitors
08/03/2005CN1649587A Use of epothilones in the treatment of brain diseases associated with proliferative processes
08/03/2005CN1649586A Heterocyclic amide derivatives for the treatment of diabetes and other diseases
08/03/2005CN1649585A Epothilone derivative for the treatment of hepatoma and other cancer diseases
08/03/2005CN1649584A Antibacterial compositions comprising metal phthalocyanine analogues
08/03/2005CN1649583A Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
08/03/2005CN1649582A Amino-methyl substituted tetracycline compounds
08/03/2005CN1649581A Substituted 3-amino-thieno(2, 3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
08/03/2005CN1649580A Pharmaceutical composition comprising a lipase inhibitor and glucomannan
08/03/2005CN1649579A N-acylaminoacetonitrile derivatives and their use for controlling parasites
08/03/2005CN1649578A Nematicidal fatty acid and fatty acid ester related compounds
08/03/2005CN1649577A Preventing and/or treating cardiovascular disease and/or associated heart failure
08/03/2005CN1649576A Methods and compositions for treatment of cancer pain
08/03/2005CN1649575A Method of treating vascular endothelial growth factor mediated vascular disorders using amfenac or nepafenac
08/03/2005CN1649574A Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
08/03/2005CN1649569A Controlled release dosage forms
08/03/2005CN1649568A Pharmaceutical compositions for the treatment of asthma
08/03/2005CN1649551A Drug-delivery endovascular stent and method for treating restenosis
08/03/2005CN1649517A Soft drink replacer
08/03/2005CN1649515A Compositions comprising milk protein concentrate and fatty acid and processes of their preparation
08/03/2005CN1649514A Compositions comprising protein and fatty acid and processes of their preparation
08/03/2005CN1649513A Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
08/03/2005CN1648258A Compound 4-methoxy-7-methyl-3-oxo-1, 3-dihydro isophenol furan-5-formaldehyde and its preparing method
08/03/2005CN1648249A Small molecular interference ribonucleic acid for inhibiting SARS virus gene expression
08/03/2005CN1648136A Companumoea root polyose, derivative and its preparing method and use
08/03/2005CN1648128A Aromatic heterocyclic carboxylic derivative, preparing method and use on medicine
08/03/2005CN1648126A Compound and its preparing method and use
08/03/2005CN1648121A Quinoline deravative, preparing method and its use
08/03/2005CN1647803A Chinese medicine composition plaster for external anti-inflammation and analgetics
08/03/2005CN1647797A Formula of submicro emulsion of norcantharidine injection and preparing process
08/03/2005CN1647796A Use of Levo-butylphthalide in preparing medicine for preventing and treating cerebral ischemia diseases
08/03/2005CN1647795A Fatty acyl acetaldehyde transfusion preparation and its preparing method
08/03/2005CN1647794A Fatty acyl acetaldehyde powder projection and its preparing method
08/03/2005CN1647697A Health food containing chitin and its preparing method
08/03/2005CN1647695A Himematsutake water soluble polysaccharide and its preparing process and use
08/03/2005CN1647634A Diacid dioxide disinfectant liquid
08/03/2005CN1213145C Modified EB virus LMP1 coding sequence and its prepn and application
08/03/2005CN1213071C Sulfated polyguluronic Acid Ester and its preparation method and uses
08/03/2005CN1213059C Rapid dehydration of proteins
08/03/2005CN1213058C FAP-activated anti-tumor compounds
08/03/2005CN1213056C Structure and uses of autisense oligodeoxynucleotide for treating thrombus disease
08/03/2005CN1213055C Novel ribose-substituted aromatic amides, method for prodn. and use thereof as medicaments
08/03/2005CN1213049C Alkylated imidazopyridine derivatives and medicine containing them and use
08/03/2005CN1213047C Puring derivatives inhibitors of tyrosine kinase SYK
08/03/2005CN1213046C Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors
08/03/2005CN1213045C Tyrosine kinase inhibitors
08/03/2005CN1213044C Amine and amide derivatives as ligands for neuropeptide YY5 receptor useful in treatment of obesity and other disorders
08/03/2005CN1213042C Novel taxoids, preparation thereof and pharmaceutical compositions containing same
08/03/2005CN1213040C Serine protese inhibitors
08/03/2005CN1213038C Benzophenones as inhibitors of reverse transcriptase
08/03/2005CN1213036C Novel amide derivatives
08/03/2005CN1213033C Crystalline bis [(E)-7[4-(4-(4-fluorophenyl)-6-isopropy-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl] (3R,5S-3,5-dihydroxyhept-6-enoic acid] calcium salt
08/03/2005CN1213029C S-Ht receptor agonist and its preparing method for salt
08/03/2005CN1213028C Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl IV, processes for their preparation, and their use
08/03/2005CN1213026C Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
08/03/2005CN1213025C 硫代酰胺衍生物 Thioamide derivatives
08/03/2005CN1213022C Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
08/03/2005CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors
08/03/2005CN1213020C Phenylalaninol derivatives
08/03/2005CN1213017C Propynyl or diene diaryl compounds
08/03/2005CN1212861C Preventives or remedies for myocarditis, dilated cardiomyopathy and cardiac insufficiency containing NF-K B inhibitors as the active ingredient
08/03/2005CN1212857C Osteodynia alleviating and wind dispelling liniment
08/03/2005CN1212854C Compound prunella spike capsule and preparation process thereof
08/03/2005CN1212848C L-histidine in ophthalmic solutions
08/03/2005CN1212847C Improved ophthalmic and contact lens solutions containing forms of vitamin B
08/03/2005CN1212846C Preparing process of anticoagulant konjak glucomanan sulfate
08/03/2005CN1212845C Use of low-molecular-weight heparins for preventing and treating central nervous system trauma
08/03/2005CN1212844C Helicid powder injection preparation and its preparation method
08/03/2005CN1212843C Egg yolk lecithin soft capsule and its production process
08/03/2005CN1212842C Melazocine masticatory and its preparation
08/03/2005CN1212841C Amelioration of apomorphine adverse effects
08/03/2005CN1212840C Slow-releasing kurarinol preparation and its preparing method
08/03/2005CN1212839C Use of substituted pyrazoles in preparing medicine for treating allergies
08/03/2005CN1212838C Controlled-release dosage forms comprising zolpidem or salt thereof
08/03/2005CN1212837C Micro-pillet preparation of ranitidine
08/03/2005CN1212836C Compositions for ameliorating attention-deficient/hyperactivity disorder
08/03/2005CN1212834C Fluoxetine enteric soluble micro-capsule
08/03/2005CN1212833C Orally administered pharmaceutical formulations of benzimidazole derivatives and the method of preparing the same
1 ... 4595 4596 4597 4598 4599 4600 4601 4602 4603 4604 4605 4606 4607 4608 4609 4610 4611 4612 4613 4614 4615 ... 7860